SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-23-000227
Filing Date
2023-05-12
Accepted
2023-05-12 17:16:08
Documents
72
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED MARCH 31, 2023 bivi-20230331_10q.htm   iXBRL 10-Q 1072337
2 EXHIBIT 31.1 bivi-20230331_10qex31z1.htm EX-31.1 12092
3 EXHIBIT 31.2 bivi-20230331_10qex31z2.htm EX-31.2 12260
4 EXHIBIT 32.1 bivi-20230331_10qex32z1.htm EX-32.1 5281
5 EXHIBIT 32.2 bivi-20230331_10qex32z2.htm EX-32.2 5134
  Complete submission text file 0001520138-23-000227.txt   5607920

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bivi-20230331.xsd EX-101.SCH 51784
7 XBRL CALCULATION FILE bivi-20230331_cal.xml EX-101.CAL 50883
8 XBRL DEFINITION FILE bivi-20230331_def.xml EX-101.DEF 162047
9 XBRL LABEL FILE bivi-20230331_lab.xml EX-101.LAB 331992
10 XBRL PRESENTATION FILE bivi-20230331_pre.xml EX-101.PRE 278665
66 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20230331_10q_htm.xml XML 918049
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39015 | Film No.: 23917020
SIC: 2834 Pharmaceutical Preparations